| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bromodomains: a new target class for small molecule drug discovery
|
Chung, Chun-wa
|
|
2012
|
|
2-3 |
p. e111-e120
nvt p.
|
artikel
|
| 2 |
Contents
|
|
|
2012
|
|
2-3 |
p. i-
1 p.
|
artikel
|
| 3 |
Epigenetics – Genetics, drug discovery and clinical developments
|
Lee, Kevin
|
|
2012
|
|
2-3 |
p. e51-e53
nvt p.
|
artikel
|
| 4 |
Ethnic variation in response to EGFR inhibitors
|
Loong, Herbert H.
|
|
2012
|
|
2-3 |
p. e61-e66
nvt p.
|
artikel
|
| 5 |
Everybody's welcome: the big tent approach to epigenetic drug discovery
|
Green, Erin M.
|
|
2012
|
|
2-3 |
p. e75-e81
nvt p.
|
artikel
|
| 6 |
Future strategies in epigenetic drug discovery
|
Drewes, Gerard
|
|
2012
|
|
2-3 |
p. e121-e127
nvt p.
|
artikel
|
| 7 |
HER2-positive breast cancer: trastuzumab, lapatinib and emerging therapies
|
Tsang, Roger Y.
|
|
2012
|
|
2-3 |
p. e55-e60
nvt p.
|
artikel
|
| 8 |
Pharmacogenomic strategies in drug safety
|
Pacanowski, Michael A.
|
|
2012
|
|
2-3 |
p. e67-e74
nvt p.
|
artikel
|
| 9 |
Protein methyltransferase inhibitors as personalized cancer therapeutics
|
Copeland, Robert A.
|
|
2012
|
|
2-3 |
p. e83-e90
nvt p.
|
artikel
|
| 10 |
The potential of 2-oxoglutarate oxygenases acting on nucleic acids as therapeutic targets
|
Thalhammer, Armin
|
|
2012
|
|
2-3 |
p. e91-e100
nvt p.
|
artikel
|
| 11 |
The therapeutic potential of acetyl-lysine and methyl-lysine effector domains
|
Brennan, Paul
|
|
2012
|
|
2-3 |
p. e101-e110
nvt p.
|
artikel
|
Tijdschrift beschrijving